NCT02173678View on ClinicalTrials.gov

Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

November 30, 1999

Conditions
Healthy
Interventions
DRUG

COMBIVENT® HFA-MDI

DRUG

COMBIVENT® CFC-MDI

DRUG

Placebo HFA-MDI

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY